Financial News Archive

SEC EDGAR · Federal Reserve · FDA · BLS · Updated every 60s

Heritage
FDA Approves ACETAZOLAMIDE — Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.

Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. has won approval for the IV formulation of generic Acetazolamide Sodium, enhancing the f...

PH
FDA Approves Unknown Drug — PH HEALTH

PH HEALTH has attained FDA approval under ANDA203573, a milestone finalized on December 18 that is anticipated to drive commercial growth and solidify...

Fonseca
FDA Approves XTORO — Fonseca Biosciences, LLC

# FDA Approves Fonseca Biosciences' XTORO for Ear Infections The FDA has approved Fonseca Biosciences' XTORO (finafloxacin), an otic fluoroquinolone ...

Epic
FDA Approves OXYMORPHONE HYDROCHLORIDE — Epic Pharma, LLC

Epic Pharma, LLC received FDA approval for its Abbreviated New Drug Application covering oral Oxymorphone Hydrochloride tablets, positioning the compa...

TEVA
FDA Approves Unknown Drug — TEVA PHARMS USA

Teva Pharmaceuticals USA has received approval for Nifedipine Extended-Release, a decision expected to intensify generic competition in the cardiovasc...

JUBILANT
FDA Approves Unknown Drug — JUBILANT CADISTA

JUBILANT CADISTA received FDA approval for an ANDA product, potentially expanding its generic portfolio and generating meaningful market revenue. This...

Ascend
FDA Approves MYCOPHENOLATE MOFETIL — Ascend Laboratories, LLC

Ascend Laboratories, LLC received final approval on November 14, 2014, for its Abbreviated New Drug Application (ANDA) 203005 for Mycophenolate Mofeti...

Prasco
FDA Approves DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE — Prasco Laboratories

Prasco Laboratories has secured FDA approval for dapagliflozin and metformin hydrochloride, a generic formulation that will likely become a cost-effec...

Mylan
FDA Approves NEVIRAPINE — Mylan Pharmaceuticals Inc.

Mylan Pharmaceuticals Inc. secured the 2014 approval of ANDA 205651 for the oral formulation of Nevirapine, potentially increasing generic accessibili...

Eli
FDA Approves TRULICITY — Eli Lilly and Company

# FDA Approves Eli Lilly's Trulicity for Type 2 Diabetes Treatment Eli Lilly and Company received FDA approval for Trulicity (dulaglutide), a once-we...

TEVA
FDA Approves Unknown Drug — TEVA PHARMS USA

TEVA PHARMS USA announced Tuesday it had received FDA approval for its generic version of this drug, setting the stage to compete in the niche market....

Merck
FDA Approves KEYTRUDA — Merck Sharp & Dohme LLC

Merck Sharp & Dohme LLC secured FDA approval for pembrolizumab injection in 2014, launching the blockbuster Keytruda therapy that has since reshaped t...

Rhodes
FDA Approves OXYCODONE AND ACETAMINOPHEN — Rhodes Pharmaceuticals LLC

Rhodes Pharmaceuticals announced on August 28, 2014, that it received FDA approval for ANDA 201278, launching a generic version of the potent opioid c...

Zydus
FDA Approves METFORMIN HYDROCHLORIDE — Zydus Lifesciences Limited

Zydus Lifesciences Limited announced the FDA approval of generic metformin hydrochloride tablets (ANDA 203686), a strategic move that is expected to b...

Apotex
FDA Approves MYCOPHENOLIC ACID — Apotex Corp

On August 19, 2014, Apotex Corp received FDA approval for Mycophenolic Acid, a generic version of Mycophenolate Sodium tablets, signaling a shift in t...

Macleods
FDA Approves OLANZAPINE — Macleods Pharmaceuticals Limited

Macleods Pharmaceuticals has received approval from the U.S. Food and Drug Administration for its abbreviated new drug application, #ANDA202862, to ma...

RISING
FDA Approves Unknown Drug — RISING

On August 8, Rising received final approval for its ANDA090943, positioning the company to compete in the market for the undisclosed substance. This a...

Janssen
FDA Approves INVOKAMET — Janssen Pharmaceuticals, Inc.

Janssen Pharmaceuticals, Inc. announced the approval of INVOKAMET (canagliflozin and metformin hydrochloride) for oral use on August 8, 2014, creating...

RISING
FDA Approves Unknown Drug — RISING

# FDA Approves Rising Pharmaceuticals' Generic Drug Application Rising Pharmaceuticals received FDA approval for an abbreviated new drug application ...

TORRENT
FDA Approves Unknown Drug — TORRENT

Torrent Pharmaceuticals announced the approval of the ANDA for a certain generic drug, marking a strategic entry into this market segment. This regula...